한글목차

위축성 흉터 치료 시장 규모는 2025년 40억 2,000만 달러에서 2034년에는 62억 2,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 4.97%로 성장할 전망입니다.

위축성 흉터 치료 시장은 여드름, 외과적 상처 등 흉터를 유발하는 피부 질환의 증가를 배경으로 괄목할 만한 성장을 거듭하고 있습니다. 미용에 대한 관심이 높아짐에 따라 소비자들은 피부의 질감과 외관을 개선할 수 있는 효과적인 솔루션을 찾고 있습니다. 레이저 치료, 마이크로 니들링, 피부 필러 등의 치료법 혁신으로 위축성 흉터 관리 분야는 크게 변화하고 있습니다. 이러한 첨단 기술은 치료 효과를 높일 뿐만 아니라 회복 기간을 최소화하기 때문에 보다 폭넓은 계층에게 받아들여지고 있습니다.

또한, 위축성 흉터 치료 시장에서는 개인별 맞춤 치료 계획이 도입되고 있습니다. 의료진은 첨단 진단 도구와 환자의 피드백을 활용해 개인의 피부 질과 흉터 특성에 맞는 치료법을 제안하고 있습니다. 이러한 추세는 환자 개개인의 고유한 니즈를 고려한 종합적인 접근 방식으로의 전환을 반영하고 있으며, 이는 환자 만족도와 치료 결과의 향상으로 이어지고 있습니다. 또한, 여러 치료법을 시너지 효과를 낼 수 있는 복합요법의 보급으로 흉터 치료에 대한 종합적인 솔루션을 제공하고 있습니다.

또한, 소셜 미디어와 온라인 플랫폼의 영향력 확대로 위축성 흉터 치료의 수요가 증가하고 있습니다. 개인들이 치료 경험과 결과를 공유하면서 소비자들의 관심이 높아져 문의와 예약이 증가하고 있습니다. 또한, 편의성과 경제성을 추구하는 소비자들을 위해 외용 크림이나 기기 등 재택 치료 옵션도 증가하고 있습니다. 요약하면, 위축성 흉터 치료 시장은 기술 발전, 맞춤형 치료, 미적 결과에 대한 관심 증가로 인해 꾸준히 확대될 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 위축성 흉터 치료 시장 : 제품 유형별

제5장 세계의 위축성 흉터 치료 시장 : 유통 채널별

제6장 세계의 위축성 흉터 치료 시장 : 지역별

제7장 경쟁 구도

제8장 기업 개요

영문목차

The Atrophic Scar Treatment Market size is expected to reach USD 6.22 Billion in 2034 from USD 4.02 Billion (2025) growing at a CAGR of 4.97% during 2026-2034.

The atrophic scar treatment market is experiencing significant growth, driven by the increasing prevalence of skin conditions that lead to scarring, such as acne and surgical wounds. As awareness of aesthetic concerns rises, consumers are seeking effective solutions to improve skin texture and appearance. Innovations in treatment modalities, including laser therapies, microneedling, and dermal fillers, are transforming the landscape of atrophic scar management. These advanced techniques not only enhance the efficacy of treatments but also minimize recovery time, making them appealing to a broader demographic.

Moreover, the integration of personalized treatment plans is gaining traction within the atrophic scar treatment market. Practitioners are leveraging advanced diagnostic tools and patient feedback to tailor interventions that address individual skin types and scar characteristics. This trend reflects a shift towards more holistic approaches that consider the unique needs of each patient, thereby improving satisfaction and outcomes. Additionally, the rise of combination therapies, which synergistically utilize multiple modalities, is becoming increasingly popular, offering comprehensive solutions for scar treatment.

Furthermore, the growing influence of social media and online platforms is propelling the demand for atrophic scar treatments. As individuals share their experiences and results, consumer interest is heightened, leading to increased inquiries and bookings. The market is also witnessing a rise in at-home treatment options, such as topical creams and devices, catering to consumers seeking convenience and affordability. In summary, the atrophic scar treatment market is set for robust expansion, characterized by technological advancements, personalized care, and a heightened focus on aesthetic outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Laser
• Surface treatment
• Injectable
• Topical

By Distribution Channel

• Clinics
• Pharmacies and drug stores
• Hospitals
• E-Commerce

COMPANIES PROFILED

• Cynosure, Merz Pharma, Perrigo Company plc, CCA Industries Inc, Lumenis, Candela Corporation, Pacific World Corporation, Bausch Health, Sonoba, Otonomy Inc, Mlnlycke Health Care AB, Shanghai Fosun Pharmaceutical Group Co Ltd, Beijing Toplaser Technology Co Ltd, Smith Nephew plc, Rejvaskin, BristolMyers Squibb Company, Torrent Pharmaceuticals Ltd, Novus Therapeutics Inc, Pediapharm Inc, Intas Pharmaceuticals Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATROPHIC SCAR TREATMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Laser Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Surface treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATROPHIC SCAR TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pharmacies and drug stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATROPHIC SCAR TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ATROPHIC SCAR TREATMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Cynosure
  • 8.2.2 Merz Pharma
  • 8.2.3 Perrigo Company Plc
  • 8.2.4 CCA Industries Inc
  • 8.2.5 Lumenis
  • 8.2.6 Candela Corporation
  • 8.2.7 Pacific World Corporation
  • 8.2.8 Bausch Health
  • 8.2.9 Sonoba
  • 8.2.10 Otonomy Inc
  • 8.2.11 MA¶Lnlycke Health Care AB
  • 8.2.12 Shanghai Fosun Pharmaceutical (Group) Co. Ltd
  • 8.2.13 Beijing Toplaser Technology Co. Ltd
  • 8.2.14 Smith & Nephew Plc
  • 8.2.15 RejAfAVaskin
  • 8.2.16 Bristol-Myers Squibb Company
  • 8.2.17 Torrent Pharmaceuticals Ltd
  • 8.2.18 Novus Therapeutics Inc
  • 8.2.19 Pediapharm Inc
  • 8.2.20 Intas Pharmaceuticals Ltd